Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001493152-25-002756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 2025-01-15 | AIM | BRYAN NANCY | Dir | A - Grant | $0.19 | +27.4K | 139.3K | +25% | +$5,208 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | A | A | 27,412 | $0.19 | 139,276 | D | — | — | (F1) The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |